← Companies

REG1V

Revenio Group

Main Market Mid Health care FI0009010912
In FY2025 the chair received €95,999; the approved annual chair fee was €60,000 (40% in shares).

Board paid total FY2025

€165,998

2 directors · €82,999 / seat · Board

CEO total remuneration FY2025

€480,137

Jouni Toijala · CEO

Board look-through

Board paid — amounts paid by director · Shares = share-based fee EUR (ownership count in paren when known)

Director Role Annual Meetings Committee Shares Total Ownership %
Arne Boye Nielsen Chair · Audit member €41,992 €26,000 €28,007 (3,693) €95,999
Bill Östman Vice chair · Nomination Rem Chair €32,991 €15,000 €22,008 (4,178) €69,999

Source: company rem report · Shares column is share-based fee EUR from the rem report; count in parentheses is year-end holding when disclosed. Browse all directors on People.

CEO remuneration

Executive pay from the rem report — separate from board fees. Ownership and tenure when disclosed.

CEO FY Tenure Ownership Base STI LTI Other Pension Total
Jouni Toijala 2025 €480,137

Source reports

  • Corporate governance statement · FY2025
    EN
    Open ↗
  • Remuneration report · FY2025
    EN
    Open ↗

Source: company rem report

At a glance

Approved chair fee

€60,000

40% in shares

Approved member fee

€30,000

Approved fee schedule

Role FY Annual fee Meeting fee Share portion
Chair 2025 €60,000 40%
Vice chair 2025 €45,000 40%
Member 2025 €30,000 40%
Audit chair 2025 €20,000
Committee member 2025 €5,000
Meeting Fee Chair 2025 €1,000
Meeting Fee Member 2025 €600
Nomination Rem Chair 2025 €10,000